"Bipolar Disorder - Drug Pipeline Assessment and Market Forecasts to 2017" Published

Nov. 14, 2010 - PRLog -- GlobalData, the industry analysis specialist, has released its new report, "Bipolar Disorder - Drug Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Bipolar Disorder market. The report identifies the key trends shaping and driving the global Bipolar Disorder market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Bipolar Disorder sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData estimates that the global Bipolar Disorder market was valued at $4.4 billion in 2009 and is forecast to decline by 10% annually for the next seven years to reach $1.9 billion by 2017. This modest decline in the forecast is primarily attributed to the patent expiry of all the major marketed products, the availability of the generic versions of those products, and the strong competition in the market. The Bipolar Disorder market is primarily formed of generic and off-label drugs and has very few approved drugs which fall in the major therapeutic categories such as Dopamine and Serotonin Antagonist and Sodium and calcium channel inhibitors.

Scope

The report provides information on the key drivers and challenges of the Bipolar Disorder market. Its scope includes:  

* Annualized global Bipolar Disorder market revenues data from 2001 to 2009, forecast for eight years to 2017. Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as Dopamine Receptor Antagonist, Neuroprotectants, Sodium Channel Inhibitors, Glutamate receptor antagonist, Selective Serotonin Reuptake Inhibitors and the like.
* Analysis of the current and future competition in the global Bipolar Disorder market. Key market players covered are Gedeon Richter Plc, Dainippon Sumitomo Pharma Co., Ltd. Cephalon, Inc. and Janssen Pharmaceutica.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Bipolar Disorder therapeutics market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Bipolar Disorder market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Bipolar Disorder market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Bipolar Disorder market landscape? - Identify, understand and capitalize.


For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/92032_bipolar_disorder_drug_pi...


Partial Table of Contents:

1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Bipolar Disorder: Introduction 6
2.1 GlobalData Pipeline Report Guidance 7
3 Bipolar Disorder: Market Characterization 8
3.1 Overview 8
3.2 Bipolar Disorder Market Size 8
3.3 Bipolar Disorder Market Forecast and CAGR 9
3.4 Drivers and Barriers for the Bipolar Disorder Market 10
3.4.1 Drivers for the Bipolar Disorder Market 10
3.4.2 Barriers for the Disorder Market 10
3.5 Opportunity and Unmet Need 11
3.6 Key Takeaway 12
4 Bipolar Disorder Market: Competitive Assessment 13
4.1 Overview 13
4.2 Strategic Competitor Assessment 13
4.3 Product Profile for the Major Marketed Products in the Bipolar Disorder Market 14
4.3.1 Abilify (Aripiprazole) 14
4.3.2 Symbyax (Olazapine and fluoxetine Hcl) 15
4.3.3 Geodon (Ziprasidone Hydrochloride) 16
4.3.4 Zyprexa (olazapine) 17
4.3.5 Equetro (carbamazepine) 18
4.3.6 Seroquel (Quetiapine Fumarate) 19
4.3.7 Saphris (SYNCREST, ORG-5222, Asenapine) 21
4.4 Major Marketed Products Comparison in the Bipolar Disorder Market 22
4.5 Key Takeaway 23
5 Bipolar Disorder Market: Pipeline Assessment 24
5.1 Overview 24
5.2 Strategic Pipeline Assessment 24
5.2.1 Technology Trends Analytical Framework 24
5.3 Bipolar Disorder Therapeutics - Promising Drugs under Clinical Development 26
5.4 Molecule Profile for Promising Drugs Under Clinical Development 26
5.4.1 Lurasidone (SM-13496) 26
5.4.2 Nuvigil (armodafinil) 27
5.4.3 Invega (Paliperidone) 28
5.4.4 RGH-188 (Cariprazine) 29
5.5 Bipolar Disorder Therapeutics Market - Clinical Pipeline by Therapeutic Class 30
5.6 Bipolar Disorder Disease Pipeline - Pipeline by Clinical Phases of Development 30
5.7 Bipolar Disorder Therapeutics - Phase III Clinical Pipeline 31
5.8 Bipolar Disorder Therapeutics - Phase II Clinical Pipeline 31

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=9203...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.